论文部分内容阅读
目的 探讨有合并症冠心病患者经皮冠状动脉介入治疗 (PCI)的有效性和安全性。方法 4 6例有合并症冠心病患者均行经皮冠状动脉腔内成形术 (PTCA)和 /或支架置入术 ,针对不同合并症 ,制定相应的血运重建方案 ,如充分的术前准备、术中合理技术操作等 ,并定期随访 15± 7.6个月。结果 4 6例患者 ,直接PTCA 5例 ,直接支架置入 17例 ,PTCA和支架置入 2 4例 ,共置入支架 4 9枚 ,1例PTCA未成功 ,PCI成功率 97.8%。 4例病人复发心绞痛 ,1例术后 12个月死于室颤。结论 有合并症冠心病患者的PCI治疗 ,采取个体化血运重建治疗方案 ,可显著降低PCI的风险性 ,取得无合并症冠心病患者近似的临床效果。
Objective To investigate the efficacy and safety of percutaneous coronary intervention (PCI) in patients with comorbid coronary heart disease. Methods Twenty - six patients with coronary heart disease complicated with coronary heart disease underwent percutaneous transluminal coronary angioplasty (PTCA) and / or stenting. According to the different complications, a corresponding revascularization plan was developed, such as adequate preoperative preparation, Intraoperative reasonable technical operation, etc., and regular follow-up of 15 ± 7.6 months. Results Among the 46 patients, direct PTCA was performed in 5 cases, direct stent placement in 17 cases, PTCA placement in 24 cases and stent placement in 49 cases. One case failed PTCA and the success rate of PCI was 97.8%. Four patients had recurrent angina and one patient died of ventricular fibrillation 12 months after operation. Conclusions PCI in patients with coronary artery disease with coronary heart disease and individualized revascularization therapy can significantly reduce the risk of PCI and achieve similar clinical results in patients with coronary heart disease without comorbidity.